Investor mix
5 investors on record; lead investors include Alta Partners, Sutter Hill Ventures, Perceptive Advisors.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Private equity | 1 | 20% |
| Other / undisclosed | 1 | 20% |
Anti-viral drug discovery and development based on protease inhibitor
5 investors on record; lead investors include Alta Partners, Sutter Hill Ventures, Perceptive Advisors.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Private equity | 1 | 20% |
| Other / undisclosed | 1 | 20% |